Síndrome de sjögren: revisão de literatura da farmacoterapia e perspectivas futuras

Abstract

INTRODUCTION: Sjögren's Syndrome, which (SS) is a little-known pathology, although it is one of the most common chronic rheumatic inflammatory diseases, almost as common as systemic lupus erythematosus. SS is defined as a chronic inflammatory disease of the connective tissue, of an autoimmune nature and of slow progression, which mainly affects the exocrine glands, the salivary and lacrimal glands. OBJECTIVES: To understand the pharmacological treatment recommended in Sjögren's syndrome and to know the prospects for new treatments related to this pathology. METHODOLOGY: For this purpose, a bibliographic, exploratory study was carried out through a literature review. The data were collected through searches in virtual health databases, in the Virtual Health Library - VHL, Latin American and Caribbean Health Sciences Information System (LILACS), National Library of Medicine (MEDLINE), Scielo, Pubmed, bank of theses and books. RESULTS: Based on the results obtained, SS is truly little known despite how it has already been explained to affect many people, as well as the ways in which they are treated are controversial and often experimental, a fact that demonstrates the relevance and the paramount importance of that research. CONCLUSION: Therefore, in view of the facts observed, it is concluded the importance of more in- depth studies on the subject addressed and greater advances in their treatments and medications for patients, thus reiterating the eminent importance of the present study to support future research. once.